Related Experiment Video
Updated: May 28, 2025

09:43
Using Optogenetics to Reverse Neuroplasticity and Inhibit Cocaine Seeking in Rats
Published on: October 5, 2021
2.4K
Cholecystokinin Modulates Corticostriatal Transmission and Plasticity in Rodents
Chloé Guillaume1, María Sáez2, Patricia Parnet3
1Nantes Université, INRAe, UMR 1280 PhAN, IMAD, Nantes F-44000, France vincent.paille@univ-nantes.fr cg829@cam.ac.uk.
Eneuro
|February 14, 2025
Summary
Cholecystokinin (CCK) plays a key role in synaptic plasticity and memory. This study reveals CCK modulates striatal medium spiny neuron excitability and corticostriatal transmission via CCK2R, impacting motor control mechanisms.
Area of Science:
- Neuroscience
- Synaptic Plasticity
- Neuropeptide Signaling
Background:
- Cholecystokinin (CCK) is recognized as a crucial neuropeptide involved in synaptic plasticity and memory.
- Its role in the striatum, essential for motor control, remains largely unexplored despite its abundance in basal ganglia.
Purpose of the Study:
- To investigate the role of CCK in modulating striatal medium spiny neuron (MSN) membrane properties.
- To examine CCK's influence on synaptic transmission and plasticity between the secondary somatosensory cortex (S2) and MSNs in rodents.
Main Methods:
- In vivo optopatch-clamp recordings in mice to assess CCK receptor Type 2 (CCK2R) antagonist effects on corticostriatal transmission.
- Ex vivo rat preparation to analyze CCK2R inhibition's impact on MSN membrane properties and synaptic plasticity.
Main Results:
- CCK2R antagonists decreased corticostriatal transmission in both direct and indirect pathway MSNs.
- CCK2R inhibition increased MSN excitability by reducing spike threshold and rheobase.
- CCK2R blockade shifted spike-timing-dependent plasticity from long-term potentiation to long-term depression.
Conclusions:
- CCK, primarily through CCK2R, significantly modulates corticostriatal transmission and MSN excitability.
- This research provides novel insights into striatal function and plasticity, highlighting CCK's potential relevance to basal ganglia disorders.

